The EVaging index, based on extracellular vesicle profiling, accurately predicted chronological age and was significantly associated with the 10-year likelihood of fatal cardiovascular events (OR 1.1248).
Observational (n=625)
Yes
Does the EVaging index based on serum extracellular vesicle profiling predict biological age and stratify cardiovascular risk in adults?
Profiling of serum extracellular vesicles to calculate an EVaging index may serve as a novel biomarker for assessing biological aging and stratifying cardiovascular risk.
Odds Ratio: 1.1248
p-value: p=<0.001
Extracellular vesicles (EVs) offer valuable diagnostic and prognostic insights for cardiovascular (CV) diseases, but the influence of age-related chronic inflammation ("inflammaging") and sex differences on EV profiles linked to CV risk remains unclear. This study aimed to use EV profiling to predict age and stratify patients by CV risk. We developed an EVaging index by analyzing surface antigen profiles of serum EVs from 625 participants, aged 20 to 94 years, across varying CV risk groups. The EVaging index was associated with age in healthy individuals and distinguished CV risk profiles in patients, correlating with CV outcomes and likelihood of fatal CV events according to the European Society of Cardiology (ESC) SCORE, and reflecting age-associated comorbidities. While changes in disease-related EV fingerprint adds complexity in CV patients, EV profiling may help assess biological aging and CV risk, emphasizing EVs' roles in inflammaging.
Burrello et al. (Thu,) conducted a observational in Cardiovascular risk (n=625). EVaging index (extracellular vesicle profiling) was evaluated on 10-year likelihood of fatal cardiovascular events (ESC SCORE) (OR 1.1248, p=<0.001). The EVaging index, based on extracellular vesicle profiling, accurately predicted chronological age and was significantly associated with the 10-year likelihood of fatal cardiovascular events (OR 1.1248).